Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells.

Ushiki T, Huntington ND, Glaser SP, Kiu H, Georgiou A, Zhang JG, Metcalf D, Nicola NA, Roberts AW, Alexander WS.

PLoS One. 2016 Sep 1;11(9):e0162111. doi: 10.1371/journal.pone.0162111. eCollection 2016.

2.

Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.

Ng AP, Hu Y, Metcalf D, Hyland CD, Ierino H, Phipson B, Wu D, Baldwin TM, Kauppi M, Kiu H, Di Rago L, Hilton DJ, Smyth GK, Alexander WS.

PLoS Genet. 2015 May 14;11(5):e1005211. doi: 10.1371/journal.pgen.1005211. eCollection 2015 May.

3.

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS.

Science. 2013 Nov 22;342(6161):967-70. doi: 10.1126/science.1240527.

4.

Suppressive oligodeoxynucleotides promote the development of Th17 cells.

Bode C, Yang XP, Kiu H, Klinman DM.

PLoS One. 2013 Jul 2;8(7):e67991. doi: 10.1371/journal.pone.0067991. Print 2013.

5.

Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses.

Kedzierska K, Curtis JM, Valkenburg SA, Hatton LA, Kiu H, Doherty PC, Kedzierski L.

PLoS One. 2012;7(3):e33161. doi: 10.1371/journal.pone.0033161. Epub 2012 Mar 21.

6.

Biology and significance of the JAK/STAT signalling pathways.

Kiu H, Nicholson SE.

Growth Factors. 2012 Apr;30(2):88-106. doi: 10.3109/08977194.2012.660936. Epub 2012 Feb 20. Review.

7.

IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.

Croker BA, Kiu H, Pellegrini M, Toe J, Preston S, Metcalf D, O'Donnell JA, Cengia LH, McArthur K, Nicola NA, Alexander WS, Roberts AW.

Immunol Cell Biol. 2012 Jan;90(1):124-9. doi: 10.1038/icb.2011.29. Epub 2011 Apr 26.

8.

Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.

Kiu H, Greenhalgh CJ, Thaus A, Hilton DJ, Nicola NA, Alexander WS, Roberts AW.

Growth Factors. 2009 Dec;27(6):384-93. doi: 10.3109/08977190903210954.

9.

SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.

Zhan Y, Davey GM, Graham KL, Kiu H, Dudek NL, Kay T, Lew AM.

Immunol Cell Biol. 2009 Aug-Sep;87(6):473-80. doi: 10.1038/icb.2009.23. Epub 2009 Apr 21.

PMID:
19381159
10.

SOCS regulation of the JAK/STAT signalling pathway.

Croker BA, Kiu H, Nicholson SE.

Semin Cell Dev Biol. 2008 Aug;19(4):414-22. doi: 10.1016/j.semcdb.2008.07.010. Epub 2008 Jul 30. Review.

11.

Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation.

Croker BA, Mielke LA, Wormald S, Metcalf D, Kiu H, Alexander WS, Hilton DJ, Roberts AW.

Exp Hematol. 2008 Jul;36(7):786-98. doi: 10.1016/j.exphem.2008.02.008. Epub 2008 Apr 8.

12.

Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFalpha.

Kiu H, Hilton DJ, Nicola NA, Ernst M, Marquez R, Alexander WS, Roberts AW, Mcmanus EJ.

Growth Factors. 2007 Oct;25(5):319-28. doi: 10.1080/08977190701830151.

PMID:
18236210
13.

SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Wong PK, Egan PJ, Croker BA, O'Donnell K, Sims NA, Drake S, Kiu H, McManus EJ, Alexander WS, Roberts AW, Wicks IP.

J Clin Invest. 2006 Jun;116(6):1571-81. Epub 2006 May 18.

14.

More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders.

Steensma DP, Pardanani A, Stevenson WS, Hoyt R, Kiu H, Grigg AP, Szer J, Juneja S, Hilton DJ, Alexander WS, Roberts AW.

Blood. 2006 Feb 15;107(4):1733-5; author reply 1735. No abstract available.

Supplemental Content

Support Center